Immunolocalization and activation of nuclear factor-κB in the sciatic nerves of rats with experimental autoimmune neuritis

Journal of Neuroimmunology

Volumn 174, Issue 1-2, 2006, Pages 32-38

  Laura M ^a   Mazzeo, A ^a   Aguennouz, M ^a   Santoro, M ^b   Catania, M A ^a   Migliorato, A ^a   Calapai, G ^a   Vita, G ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b Azienda Ospedale Piemonte   (Italy)

Author keywords

EMSA; Experimental autoimmune neuritis; Immunohistochemistry; NF B; Western blot

Indexed keywords

DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; BINDING AFFINITY; CELL NUCLEUS; CONTROLLED STUDY; DNA BINDING; ENDOTHELIUM CELL; ENZYME ACTIVATION; GEL MOBILITY SHIFT ASSAY; IMMUNIZATION; IMMUNOLOCALIZATION; IMMUNOREACTIVITY; MACROPHAGE; NEURITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REMISSION; SCHWANN CELL; SCIATIC NERVE; T LYMPHOCYTE; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; ECTODYSPLASINS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENZYME ACTIVATION; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; MEMBRANE PROTEINS; NEURITIS, AUTOIMMUNE, EXPERIMENTAL; NF-KAPPA B; RATS; SCIATIC NERVE; STATISTICS, NONPARAMETRIC; TIME FACTORS; TUMOR NECROSIS FACTORS;

EID: 33646084180     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2006.01.004     Document Type: Article

References (24)

1. Andorfer B., Kieseier B.C., Mathey E., Armati P., Pollard J., Oka N., and Hartung H.P. Expression and distribution of transcription factor NF-κB and inhibitor IκB in the inflamed peripheral nervous system. J. Neuroimmunol. 116 (2001) 226-232
2. Baldwin Jr. A.S. Series introduction: the transcription factor NF-κB and human disease. J. Clin. Invest. 107 (2001) 3-6
3. Barnes P.J., and Karin M. Nuclear factor-κB: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 336 (1997) 1066-1071
4. Bhakar A.L., Tannis L.L., Zeindler C., Russo M.P., Jobin C., Park D.S., MacPherson S., and Barker P.A. Constitutive nuclear factor-κB activity is required for central neuron survival. J. Neurosci. 22 (2002) 8466-8475
5. Bonetti B., Stegagno C., Cannella B., Rizzuto N., Moretto G., and Raine C.S. Activation of NF-κB and c-jun transcription factors in multiple sclerosis lesions: implications for oligodendrocyte pathology. Am. J. Pathol. 155 (1999) 1433-1438
6. Chiarugi A. Characterization of the molecular events following impairment of NF-κB-driven transcription in neurons. Mol. Brain Res. 109 (2002) 179-188
7. Gabriel C.M., Gregson N.A., Redford E.J., Davies M., Smith K.J., and Hughes R.A.C. Human immunoglobulin ameliorates rat experimental autoimmune neuritis. Brain 120 (1997) 1533-1540
8. Hartung H.P., Jung S., Stoll G., Zielasek J., Schmidt B., Archelos J.J., and Toyka K.V. Inflammatory mediators in demyelinating disorders of the CNS and PNS. J. Neuroimmunol. 40 (1992) 197-210
9. Hilliard B., Samoilova E.B., Liu T.S.T., Rostami A., and Chen Y. Experimental autoimmune encephalomyelitis in NF-κB-deficient mice: roles of NF-κB in the activation and differentiation of autoreactive T cells. J. Immunol. 163 (1999) 2937-2943
10. Kadlubowski M., Hughes R.A.C., and Gregson N.A. Experimental allergic neuritis in the Lewis rat: characterization of the activity of peripheral myelin and its major basic protein P2. Brain Res. 184 (1980) 439-454
11. Kassed C.A., Butler T.L., Patton G.W., Demesquita D.D., Navidomskis M.T., Memet S., Israel A., and Pennypacker K.R. Injury-induced NF-κB activation in the hippocampus: implications for neuronal survival. FASEB J. 18 (2004) 723-724
12. Kieseier B.C., Krivacic K., Jung S., Pischel H., Toyka K.V., Ransohoff R.M., and Hartung H.P. Sequential expression of chemokines in experimental autoimmune neuritis. J. Neuroimmunol. 110 (2000) 121-129
13. Kurz M., Pischel H., Hartung H.P., and Kieseier B.C. Tumor necrosis factor-α-converting enzyme is expressed in the inflamed peripheral nervous system. J. Peripher. Nerv. Syst. 10 (2005) 311-318
14. Laurà M., Gregson N.A., Curmi Y., and Hughes R.A.C. Efficacy of leukemia inhibitory factor in experimental autoimmune neuritis. J. Neuroimmunol. 133 (2002) 56-59
15. Lee J.I., and Burckart G.J. Nuclear factor kappa B: important transcription factor and therapeutic target. J. Clin. Pharmacol. 38 (1998) 981-993
16. Lee Y., and Shin T. Expression of constitutive endothelial and inducible nitric oxide synthase in the sciatic nerve of Lewis rats with experimental autoimmune neuritis. J. Neuroimmunol. 126 (2002) 78-85
17. Lee H.H., Dadgostar H., Cheng Q., Shu J., and Cheng G. NF-κB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 9136-9141
18. Liu S.F., Ye X., and Malik A.B. In vivo inhibition of nuclear factor-κB activation prevents inducible nitric oxide synthase expression and systemic hypotension in a rat model of septic shock. J. Immunol. 159 (1997) 3976-3983
19. Maurer M., and Gold R. Animal models of immune-mediated neuropathies. Curr. Opin. Neurol. 15 (2002) 617-622
20. Mazzeo A., Aguennouz M., Messina C., and Vita G. Immunolocalization and activation of transcription factor nuclear factor κB in dysimmune neuropathies and familial amyloidotic polyneuropathy. Arch. Neurol. 61 (2004) 1097-1102
21. Nickols J.C., Valentine W., Kanwal S., and Carter B.D. Activation of the transcription factor NF-κB in Schwann cells is required for peripheral myelin formation. Nat. Neurosci. 6 (2003) 161-167
22. O'Neill L.A., and Kaltschmidt C. NF-κB: a crucial transcription factor for glial and neuronal cell function. Trends Neurosci. 20 (1997) 252-258
23. Sousa M.M., Yan S.D., Stern D., and Saraiva M.J. Interaction of the receptor for advanced glycation end products (RAGE) with transthyretin triggers nuclear transcription factor κB (NF-κB) activation. Lab. Invest. 80 (2000) 1101-1110
24. Tak P.P., and Firestein G.S. NF-κB: a key role in inflammatory diseases. J. Clin. Invest. 107 (2001) 7-11